Cytosorbents Corporation (CTSO) financial statements (2022 and earlier)

Company profile

Business Address 7 DEER PARK DRIVE, SUITE K
MONMOUTH JUNCTION, NJ 08852
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments52,13871,42212,23222,36917,3225,2457,509
Cash and cash equivalents52,13871,42212,23222,36917,3225,2455,317
Short-term investments      2,192
Receivables4,5235,1594,4673,9432,2061,433649
Inventory, net of allowances, customer advances and progress billings4,7662,6742,1148337968341,191
Inventory4,7662,6742,1148337968341,191
Contract with customer, asset 2,997  
Other undisclosed current assets2,8722022,0881,119416316512
Total current assets:64,29982,45320,90228,26420,7397,8289,860
Noncurrent Assets
Operating lease, right-of-use asset13,4231,0291,071
Property, plant and equipment5,1512,1201,9251,7301,403569557
Restricted cash and investments1,687      
Other noncurrent assets4,9594,3483,4852,7531,9611,296837
Total noncurrent assets:25,2207,4976,4814,4833,3641,8651,394
TOTAL ASSETS:89,51989,95027,38332,74724,1039,69411,254
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,0032,4672,7772,0421,6451,844975
Accounts payable2,8051,8352,0391,4861,2441,330685
Accrued liabilities1,044632629480322478290
Employee-related liabilities154      
Interest and dividends payable  109777936 
Deferred revenue1,947728172
Debt  2,0956674,000833 
Customer advances and deposits15 30
Contract with customer, liability42
Other undisclosed current liabilities7,7396,9584,8933,7872,1883,4132,039
Total current liabilities:13,69010,1539,9366,5387,8486,0903,044
Noncurrent Liabilities
Long-term debt and lease obligation13,25158214,0289,2755,9924,078 
Long-term debt, excluding current maturities  13,3869,2755,9924,078 
Operating lease, liability13,251582643
Other undisclosed noncurrent liabilities(13,251)(582)     
Total noncurrent liabilities:13,25158214,0289,2755,9924,078 
Total liabilities:26,94110,73523,96415,81313,84010,1683,044
Stockholders' equity
Stockholders' equity attributable to parent62,57879,2163,41816,93510,263(474)8,211
Common stock43433332292525
Additional paid in capital283,194277,533191,649186,138162,907143,066140,127
Accumulated other comprehensive income (loss)526(1,734)526288(361)899584
Accumulated deficit(221,185)(196,627)(188,789)(169,524)(152,313)(144,465)(132,526)
Total stockholders' equity:62,57879,2163,41816,93510,263(474)8,211
TOTAL LIABILITIES AND EQUITY:89,51989,95027,38332,74724,1039,69411,254

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues43,16641,00524,94922,50415,1519,5284,792
Revenue, net15,1519,5284,792
Cost of revenue
(Cost of Goods and Services Sold)
(11,047)(11,052)(7,364)(7,489)(5,518)(3,954)(2,213)
Gross profit:32,11829,95217,58615,0159,6325,5742,579
Operating expenses(54,863)(40,323)(36,560)(30,599)(19,475)(17,066)(11,883)
Operating loss:(22,745)(10,370)(18,974)(15,585)(9,843)(11,492)(9,304)
Nonoperating income (expense)(2,550)1,406(1,384)(2,246)705(765)847
Foreign currency transaction gain (loss), before tax(2,578)2,607(350)(785)1,454(358)(507)
Loss from continuing operations before income taxes:(25,295)(8,964)(20,358)(17,831)(9,138)(12,257)(8,456)
Income tax benefit7361,1271,092620677319325
Net loss attributable to parent:(24,559)(7,837)(19,266)(17,211)(8,461)(11,939)(8,132)
Preferred stock dividends and other adjustments    (336)  
Net loss available to common stockholders, diluted:(24,559)(7,837)(19,266)(17,211)(8,797)(11,939)(8,132)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(24,559)(7,837)(19,266)(17,211)(8,461)(11,939)(8,132)
Comprehensive loss:(24,559)(7,837)(19,266)(17,211)(8,461)(11,939)(8,132)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2,260(2,260)238649(1,260)314357
Comprehensive loss, net of tax, attributable to parent:(22,299)(10,097)(19,028)(16,562)(9,720)(11,625)(7,775)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: